JP2006521088A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006521088A5 JP2006521088A5 JP2004570301A JP2004570301A JP2006521088A5 JP 2006521088 A5 JP2006521088 A5 JP 2006521088A5 JP 2004570301 A JP2004570301 A JP 2004570301A JP 2004570301 A JP2004570301 A JP 2004570301A JP 2006521088 A5 JP2006521088 A5 JP 2006521088A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- antibody
- variable domain
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0226728A GB0226728D0 (en) | 2002-11-15 | 2002-11-15 | Anti-activated RAS antibodies |
| GB0226731A GB0226731D0 (en) | 2002-11-15 | 2002-11-15 | Method for generating immunoglobulin genes |
| GBGB0226729.2A GB0226729D0 (en) | 2002-11-15 | 2002-11-15 | Intracellular antibodies |
| GBGB0226727.6A GB0226727D0 (en) | 2002-11-15 | 2002-11-15 | Intrabodies |
| GB0226723A GB0226723D0 (en) | 2002-11-15 | 2002-11-15 | Antibodies for in vitro use |
| GB0316680A GB0316680D0 (en) | 2003-07-16 | 2003-07-16 | Anti-activated RAS antibodies |
| PCT/GB2003/004953 WO2004046188A2 (en) | 2002-11-15 | 2003-11-14 | Anti-activated ras antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006521088A JP2006521088A (ja) | 2006-09-21 |
| JP2006521088A5 true JP2006521088A5 (https=) | 2006-11-30 |
Family
ID=32330172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004570301A Withdrawn JP2006521088A (ja) | 2002-11-15 | 2003-11-14 | 抗活性化ｒａｓ抗体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20050288492A1 (https=) |
| EP (1) | EP1565495A2 (https=) |
| JP (1) | JP2006521088A (https=) |
| AU (1) | AU2003282247A1 (https=) |
| CA (1) | CA2506128A1 (https=) |
| WO (1) | WO2004046188A2 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5171611B2 (ja) | 2005-03-25 | 2013-03-27 | ナショナル リサーチ カウンシル オブ カナダ | 可溶性ポリペプチドの単離方法 |
| EP1867661A1 (en) * | 2006-06-12 | 2007-12-19 | Diatos | Compositions and methods for delivering anti-activated ras antibodies into cells |
| EP2254366B1 (en) | 2008-03-12 | 2019-02-27 | Panasonic Intellectual Property Corporation of America | Radio communication device, radio communication system, and radio communication method |
| WO2010119249A1 (en) * | 2009-04-14 | 2010-10-21 | Trojan Technologies Ltd. | Therapeutic antennapedia-antibody molecules and methods of use thereof |
| GB201103631D0 (en) * | 2011-03-03 | 2011-04-13 | Univ Leeds | Identification of candidate therapeutics |
| RS61778B1 (sr) | 2013-05-06 | 2021-06-30 | Scholar Rock Inc | Kompozicije i postupci za modulaciju faktora rasta |
| WO2016013871A1 (ko) * | 2014-07-22 | 2016-01-28 | 아주대학교산학협력단 | 완전한 이뮤노글로불린 형태의 세포질 침투능을 갖는 항체를 이용하여 세포내 활성화된 ras를 억제하는 방법 및 그의 이용 |
| KR101602870B1 (ko) | 2014-07-22 | 2016-03-21 | 아주대학교산학협력단 | 완전한 이뮤노글로불린 형태의 항체를 세포막을 투과하여 세포질에 위치시키는 방법 및 그의 이용 |
| KR101602876B1 (ko) * | 2014-07-22 | 2016-03-11 | 아주대학교산학협력단 | 완전한 이뮤노글로불린 형태의 세포질 침투능을 갖는 항체를 이용하여 세포내 활성화된 ras를 억제하는 방법 및 그의 이용 |
| US9879087B2 (en) | 2014-11-12 | 2018-01-30 | Siamab Therapeutics, Inc. | Glycan-interacting compounds and methods of use |
| FI3218005T3 (fi) | 2014-11-12 | 2023-03-31 | Seagen Inc | Glykaanin kanssa vuorovaikutteisia yhdisteitä ja käyttömenetelmiä |
| CA3002097A1 (en) | 2015-11-12 | 2017-05-18 | Siamab Therapeutics, Inc. | Glycan-interacting compounds and methods of use |
| MX2018014554A (es) | 2016-05-27 | 2019-09-09 | Orum Therapeutics Inc | Anticuerpo penetrante de citosol y uso del mismo. |
| WO2018094143A1 (en) | 2016-11-17 | 2018-05-24 | Siamab Therapeutics, Inc. | Glycan-interacting compounds and methods of use |
| WO2018160909A1 (en) | 2017-03-03 | 2018-09-07 | Siamab Therapeutics, Inc. | Glycan-interacting compounds and methods of use |
| EP3652196A4 (en) | 2017-07-10 | 2021-08-18 | Brown, Kathlynn, C. | MOLECULAR GUIDANCE SYSTEMPEPTIDES AND USES THEREOF |
| JP2020527556A (ja) | 2017-07-10 | 2020-09-10 | エスアールアイ インターナショナルＳＲＩ Ｉｎｔｅｒｎａｔｉｏｎａｌ | がん治療用ペプチドサポリン複合体 |
| US10787487B2 (en) | 2018-06-21 | 2020-09-29 | Orum Therapeutics Inc. | Cell/tissue-specific cell-penetrating antibodies |
| GB202006974D0 (en) * | 2020-05-12 | 2020-06-24 | Univ Oxford Innovation Ltd | Chimaeric proteins and therapeutic agents |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003077945A1 (en) * | 2002-03-14 | 2003-09-25 | Medical Research Council | Intracellular antibodies |
-
2003
- 2003-11-14 EP EP03773865A patent/EP1565495A2/en not_active Withdrawn
- 2003-11-14 AU AU2003282247A patent/AU2003282247A1/en not_active Abandoned
- 2003-11-14 CA CA002506128A patent/CA2506128A1/en not_active Abandoned
- 2003-11-14 WO PCT/GB2003/004953 patent/WO2004046188A2/en not_active Ceased
- 2003-11-14 JP JP2004570301A patent/JP2006521088A/ja not_active Withdrawn
-
2005
- 2005-05-12 US US11/127,903 patent/US20050288492A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006521088A5 (https=) | ||
| JP2022061992A5 (https=) | ||
| JP2020184996A5 (https=) | ||
| JP2010535012A5 (https=) | ||
| JP2020023523A5 (https=) | ||
| JP2022502371A5 (https=) | ||
| JP2020124209A5 (https=) | ||
| AU2015322141B2 (en) | High affinity and aggregatively stable antibodies on the basis of variable domains Vl and a derivative VHH | |
| DK2036926T3 (da) | Enkeltkædet molekyle, der kan binde til flere antigener, dettes fremstilling og anvendelse | |
| HRP20110187T1 (hr) | Multispecifične deimunizirane tvari koje vežu cd3 | |
| RU2015129762A (ru) | ОДНОЛИНКЕРНЫЕ АНТИТЕЛА FabFv И СПОСОБЫ ИХ ПОЛУЧЕНИЯ | |
| JP2021525546A5 (https=) | ||
| JP2018502050A5 (https=) | ||
| JP2010511388A5 (https=) | ||
| JP2020505919A5 (https=) | ||
| JP2016531924A5 (https=) | ||
| JP2020500510A5 (https=) | ||
| JP2006506955A5 (https=) | ||
| JP2017529067A5 (https=) | ||
| JP2010500876A5 (https=) | ||
| BR122020025858B1 (pt) | Complexo de proteína biespecífico e composição compreendendo o mesmo | |
| JP2020510659A5 (https=) | ||
| JP2014158485A5 (https=) | ||
| JP2019534277A5 (https=) | ||
| JP2023509212A5 (https=) |